Halo Collective Enters into Unsecured Loan for up to $14 Million
January 6, 2022
Ryan Allway January 6th, 2022 TORONTO, Jan. 6, 2022 /CNW/ – Halo Collective Inc. (“Halo” or the “Company“) (NEO: HALO) (OTCQB: HCANF) (Germany: A9KN) today announced that it has entered into a loan agreement (the “Loan Agreement“) with Global Tech Opportunities 6 (the “Lender“), pursuant to which the Lender will loan... Read more
PharmaCielo Completes Initial Tranche of Non-Brokered Private Placement of Debenture Units
December 31, 2021
Ryan Allway December 31st, 2021 TORONTO and RIONEGRO, Colombia, Dec. 31, 2021 /CNW/ – PharmaCielo Ltd. (“PharmaCielo” or the “Company”) (TSXV: PCLO) (OTCQX: PCLOF), the Canadian parent of Colombia’s premier cultivator and producer of medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S. (“Holdings”), is pleased to announce that it has closed the first tranches of its previously announced... Read more
Aleafia Health Announces Closing of a New $19 Million Credit Facility and Extension of Existing Credit Facility
December 29, 2021
Ryan Allway December 29th, 2021 Credit Facility provides the Company with liquidity to fund operations and organic growth initiatives Two-year term provides additional financial flexibility TORONTO, Dec. 29, 2021 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce the... Read more
CaaMTech Raises $22 Million for Psychedelic Drug Discovery and Development
September 10, 2021
Ryan Allway September 10th, 2021 Psychedelics The investment provides CaaMTech with capital to advance compounds from its library into clinical trials ISSAQUAH, Wash., Sept. 08, 2021 (GLOBE NEWSWIRE) — CaaMTech, Inc., a leading psychedelic drug discovery company, has today announced the completion of a $22 million Series A financing round,... Read more
Aleafia Health Announces Closing of $10 Million Credit Facility
August 23, 2021
Ryan Allway August 23rd, 2021 Credit Facility provides financial capacity to pursue accretive growth opportunities New debt lender increases financial flexibility with new source of capital Improves liquidity by growing cash and marketable securities balance to $25 million TORONTO, Aug. 23, 2021 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSX:... Read more
Brains Bioceutical Corp. completes a USD $31.9 Million Capital Raise with Lead Investor DSM Venturing
CBD June 17, 2021
Ryan Allway June 17th, 2021 VANCOUVER, British Columbia, June 16, 2021 (GLOBE NEWSWIRE) — Brains Bioceutical Corp. (“Brains” or the “Company”) is pleased to announce the completion of a USD $31.9 million capital raise with DSM Venturing and existing Brains shareholders. DSM Venturing, who acted as lead investor in... Read more
